Global Needle-Free Devices Technologies and Markets Report 2019: 2017-2018 Analysis & CAGR Projections 2019-2023 - Increasing Demand for Painless Drug Delivery

News provided by

Apr 05, 2019, 09:30 ET

DUBLIN, April 5, 2019 /PRNewswire/ -- The "Needle-Free Devices: Technologies and Global Markets" report has been added to ResearchAndMarkets.com's offering.

This report provides a detailed description of needle-free devices and the latest technologies in the market. The report includes market estimates for different types of needle-free devices. The report also includes recent technological developments and assessments of product performance in the market.

Based on the product type, the global needle-free device market is segmented into Needle-free Injectors, Inhaler technologies, Transdermal patch technologies and Other novel technologies (e.g., microneedles and pen needles).

Based on the application, the global needle-free device market is segmented into Pain management, Vaccine delivery, Insulin delivery, and Pediatric drug delivery.

The report includes a list of marketed and pipeline products available in the market. The report discusses the qualitative and quantitative factors influencing market growth. The market drivers, restraints and opportunities are discussed in the report.

This report discusses some of the major drivers and restraints in the global needle-free device market, as well as the competition in the global needle-free device market and the key players' strategies and performances. The discussion is focused on the major market players, trends in product launches, collaborations, and mergers and acquisitions. The report also emphasizes on the company profiles of major vendors including company overview, key product offerings, financial statistics, and other developments. The report also provides insights on the market share and upcoming regional demand for the needle-less technologies.

Some of the major market players discussed in the report are 3M, Antares Pharma AG, Medtronic, Novartis, and Teva Pharmaceuticals. For market estimates, data has been provided for the year 2017 as the base year, with forecasts for 2018 through 2023. Estimated values used are based on manufacturers' total revenues. Projected and forecasted revenue values are in constant U.S. dollars, unadjusted for inflation.

The Report Includes:

36 data tables and 34 additional tables
A detailed overview of the global markets for needle-free devices and technologies within the industry
Analyses of global market trends with data from 2017 and 2018, and projections of compound annual growth rates (CAGRs) through 2023
Country-specific data and analysis for the United States, Canada, Mexico, France, Germany, U.K., Spain, China, India, Japan, South Korea, Middle East, and Africa
Assessment of the recent developments, key technological updates and product performance within the needle-free devices market
Insight into various needle-free technologies that are used in drug delivery and their various application areas
A look at the government regulations that can affect the global needle-free devices market
Identification of the competitive landscape of the market with the leading market players, suppliers and pharmaceutical partners
Profiles of major vendor companies, including 3M, AstraZeneca PLC, Bristol-Myers Squibb, GlaxoSmithKline PLC (GSK), Medtronic, Merck Serono S.A., and Teva Pharmaceutical Industries Ltd.

Major drivers of the global needle-free device market are as follows:

Increasing incidence of needlestick injuries.
Growing cases of needle phobia.
Increasing demand for painless drug delivery.
Product innovations.
Increased prevalence of diabetes globally.
Increasing incidence of blood-borne diseases globally.
Public awareness of HIV/AIDS and the significance of needle-free devices in preventing HIV.

Key Topics Covered:

Chapter 1 Introduction

Study Background
Study Goals and Objectives
Reasons for Doing This Study
Scope of Report
Information Sources
Methodology
Geographic Breakdown
Analyst's Credentials
Custom Research
Related Reports

Chapter 2 Summary and Highlights

Chapter 3 Drug Delivery Devices Structure of Human Skin

Epidermis
Dermis
Hypodermis
Overview of Drug Delivery Systems and Technologies
Needle-free Devices
Drug Delivery, by Technology
Sustained Release Drug Delivery
Prodrug
Implants and Intrauterine Devices
Targeted Drug Delivery
Polymeric Drug Delivery
Drug Delivery Systems, by Route of Administration
Oral Drug Delivery
Injectable or Parental Drug Delivery
Pulmonary Drug Delivery
Nasal Drug Delivery
Oral Mucosal Drug Delivery
Rectal Drug Delivery
Ocular Drug Delivery
Transdermal Drug Delivery
Need for Better Methods of Drug Delivery
Areas of Ongoing Research

Chapter 4 Needle-free Technology and Drug Delivery Devices

Needle-free Drug Delivery Devices and Types
History of Needle-free Devices
Demand for Needle-free Devices
Advantages of Needle-free Technology

Chapter 5 Needle-free Device Market Dynamics

Market Drivers
Increasing Incidence of Needlestick Injuries
Growing Cases of Needle Phobia
Increasing Demand for Painless Drug Delivery
Product Innovations
Increased Prevalence of Diabetes Globally
Increasing Incidence of Blood-Borne Diseases Globally
Growing Cases of HIV/AIDS
Market Restraints
Comparative High Cost of Needle-free Technology
Alternatives Available for Drug Delivery
High R&D Investments
Market Competition
Short Product Life Cycle
Competitive Landscape

Chapter 6 Market Breakdown by Product Type

Introduction
Needle-free Injectors
Introduction
Historical Background
Clinical Need
Components
Mechanism of Action
Applications
Unmet Needs
Future Developments
Needle-free Injectors Market, by Region
Needle-free Injectors Types
Needle-free Injectors, by Medication
Needle-free Injectors, by Drug Delivery
Needle-free Injectors, by Source of Power
Needle-free Injectors, by Usage Type
Inhaler Technologies
Pulmonary Drug Delivery
Advantages and Disadvantages of Inhaler Technologies
Advances in Pulmonary Drug Delivery
Future Developments
Inhaler Technologies Market, by Region
Type of Inhalers
Metered Dose Inhalers
Dry Powder Inhalers
Transdermal Patch Technologies
Transdermal Drug Delivery
Clinical Need
Historical Background
Types of Transdermal Patches
Components
Benefits of Transdermal Patches Over Other Dosage Forms
New Innovations in Transdermal Patches
Clinical Issues of Transdermal Delivery
Future Developments
Transdermal Patch Technologies Market, by Region
Other Novel Technologies
Microneedles
Pen Needles

Chapter 7 Market Breakdown by Application

Application of Needle-free Devices
Pain Management
Vaccine Delivery
Insulin Delivery
Pediatric Drug Delivery

Chapter 8 Market Breakdown by Region

Introduction
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Asia-Pacific
China
India
Japan
South Korea
Rest of Asia-Pacific
South America
Middle East and Africa

Chapter 9 Market Strategy

Market Strategy
Key Mergers and Acquisitions
Exclusive Partnership Announced by PharmaJet and Mundipharma
Aequus and Corium Jointly Collaborate for Transdermal Patches
United Therapeutics Corp. Entered into Licensing Agreement
Takeda Pharmaceutical Company and Portal Instruments Entered into Collaboration
Medherant Signed an Agreement with a Japanese Company
3M Drug Delivery System Announced Collaboration with Panacea Pharmaceutical
Cipla and MannKind Corp. Entered into Collaboration
Increasing Adoption of Home Healthcare Concept
Key Product and Technology Developments
Hind Syringes Developed Disposable Pen Needle
BD Introduced New Pen Needle
Development of Innovative Transdermal Patch Technology
Introduction of Smart Inhalers
Vaxxas' Nanopatch Garners WHO Support for Polio Vaccine Delivery

Chapter 10 Marketed and Pipeline Products

Key Marketed Products
Needle-free Injectors
Inhalers
Transdermal Patch
Other Novel Needle Technologies
Pipeline Products
Needle-free Injectors
Metered Dose Inhalers
Transdermal Patches

Chapter 11 Regulatory Structure

Regional Regulatory Structures
United States
European Union
Japan
China
Hong Kong
Korea
Taiwan
India
FDA Technical Considerations
FDA Recall and Safety Alerts
Occupational Health and Safety Laws

Chapter 12 Reimbursement and Pricing

Regional Reimbursement Structure
United States
Europe
Japan
Rest of Asia-Pacific
Pricing Trends

Chapter 13 Conclusions and Outlook for Needle-free Devices

Major Market Influencers
Social Factors
Technological Developments
Demographic and Economic Trends
Transformations in the Healthcare Industry
Future Outlook

Chapter 14 Company Profiles

3M
Activa Brand Products, Inc.
Akra Dermojet
Alkermes Plc
Amnio Technology Llc.
Antares Pharma, Inc.
Aradigm Corp.
Astellas Pharma, Inc.
Astrazeneca Plc
Battelle
Bespak Europe Ltd.
Bioject Medical Technologies
Bristol-Myers Squibb
Clearside Biomedical, Inc.
Corium International, Inc.
Crossject
Captisol
D'antonio Consultants International
Duoject Medical Systems, Inc.
Durect Corp.
Echo Therapeutics
Endo International
Ferndale Pharma Group, Inc.
Ferring Pharmaceuticals, Inc.
Gerresheimer Ag
Glaxosmithkline Plc
Glide Pharmaceutical Technologies Ltd.
Haselmeier Gmbh
Injex Pharma Ag
JCR Pharmaceuticals Co. Ltd.
Keystone Industries
Lineage Therapeutics, Inc.
Lohmann Therapie-Systeme Ag
Medical International Technologies
Medtronic
Merck Serono S.A.
Minnesota Rubber & Plastics
Mylan, Inc.
Nanopass Technologies Ltd.
National Medical Products, Inc.
Novartis
Noven Pharmaceuticals
Novo Nordisk A/S
Nypro, Inc.
Penjet Corp.
Syneron Medical Ltd.
Team Consulting Ltd.
Teva Pharmaceuticals Industries Ltd.
Theraject, Inc.
Valeritas, Inc.
Vaxxas Pty Ltd.
Ypsomed Ag
Zogenix, Inc.

For more information about this report visit https://www.researchandmarkets.com/research/xcn6wk/global?w=5

Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research.

Media Contact:

Laura Wood, Senior Manager
[email protected]

For E.S.T Office Hours Call +1-917-300-0470
For U.S./CAN Toll Free Call +1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

SOURCE Research and Markets